Home Medicine Company Completes Enrollment for Phase 2 Trial of “Immune Resetting” Peptide for... Medicine Company Completes Enrollment for Phase 2 Trial of “Immune Resetting” Peptide for Allergic Diseases By Amy Wright - January 6, 2023 35 0 FacebookTwitterPinterestWhatsApp Topline data expected in Q2 2023. Continue reading… Fitter Chewy Chocolate Chip Cookies.Propel@YH Boot Camp Announces Nordic CohortsAmy Wright
